BPMC
Blueprint Medicines Corp
Price:  
104.96 
USD
Volume:  
415,562.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

BPMC Relative Valuation

-187.5%
Upside

As of 2024-05-18, the Relative Valuation of Blueprint Medicines Corp (BPMC) is (91.79) USD. This relative valuation is based on P/E multiples. With the latest stock price at 104.96 USD, the upside of Blueprint Medicines Corp based on Relative Valuation is -187.5%.

The range of the Relative Valuation is (80.60) - (119.52) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 16.4x - 26.0x 17.8x
Forward P/E multiples 17.6x - 26.1x 22.2x
Fair Price (80.60) - (119.52) (91.79)
Upside -176.8% - -213.9% -187.5%
104.96 USD
Stock Price
(91.79) USD
Fair Price

BPMC Relative Valuation - Historical P/E Data

Date P/E
2024-05-17 -22.87
2024-05-16 -23.23
2024-05-15 -23.27
2024-05-14 -22.98
2024-05-13 -23.54
2024-05-10 -23.25
2024-05-09 -23.60
2024-05-08 -23.70
2024-05-07 -23.65
2024-05-06 -23.15
2024-05-03 -23.35
2024-05-02 -23.31
2024-05-01 -20.67
2024-04-30 -19.90
2024-04-29 -20.28
2024-04-26 -20.26
2024-04-25 -19.77
2024-04-24 -20.10
2024-04-23 -20.11
2024-04-22 -19.74
2024-04-19 -18.92
2024-04-18 -19.37
2024-04-17 -19.26
2024-04-16 -18.76
2024-04-15 -18.56
2024-04-12 -19.01
2024-04-11 -20.10
2024-04-10 -19.72
2024-04-09 -20.09
2024-04-08 -19.94
2024-04-05 -19.97
2024-04-04 -19.76
2024-04-03 -20.09
2024-04-02 -19.95
2024-04-01 -21.01
2024-03-28 -20.67
2024-03-27 -20.65
2024-03-26 -19.54
2024-03-25 -19.22
2024-03-22 -18.96
2024-03-21 -19.62
2024-03-20 -19.23
2024-03-19 -19.17
2024-03-18 -18.92
2024-03-15 -19.72
2024-03-14 -19.11
2024-03-13 -19.74
2024-03-12 -19.54
2024-03-11 -19.49
2024-03-08 -20.11